Mark Skousen
Forecasts & Strategies
Jim Powell
Global Changes & Opportunities Report
Ian Wyatt
Top Stock Insights
J. Royden Ward
Cabot Benjamin Graham Value Letter

F5 Networks: High quality tech on sale


Bookmark and Share
by Geoffrey Seiler, editor BullMarket.com

Geoffrey SeilerLong-time investors know that the behavior of Mr. Market can lead to head scratching. For long spells he can be epitome of sobriety, seeing value for what it is and acting to bid up the prices of good companies.

At other times, he's the town drunk, blindly selling a quality name out of fear. A case in point is what's happened to shares of the F5 Networks (FFIV) since trading near its one-year high in early May and then falling over 30%.

F5 is a Seattle-based technology company whose Application Delivery Networking (ADN) technology is used to manage data traffic between users and application servers in data centers.

As more of the data people and companies rely on moves to the cloud, F5's technology increasingly occupies what management says is a sweet spot in the data center.

Given its established presence in data centers around the world and the increasingly large amounts of data flowing over the Internet and private networks, how do you explain the stock's -32% plunge from the $136 level in early May to its $91.36 close last night?    


F5 does have exposure to the federal government sector, but Washington's problems didn't just appear out of thin air; they've been known for some time.

While investors have turned skittish towards large-cap tech stocks, the sell-off in F5's shares intrigues us. This is a company that continues to ride some strong secular tailwinds, such as the explosive growth of cloud computing, the build-out of virtual desktop infrastructure, and the growing use of smartphones.

We honestly don't see those trends abating any time soon, or companies completely backing away from needed investments related to those strong currents though some slowdown in spending is possible, we suppose.

F5 reports next week and we would expect it to deliver another solid quarter, but all eyes will be on guidance.

The company's performance has been exceptional and the 20% growth target seems attainable. Given the sell-off we think the stock is looking attractive.

Strip out its $13.08 per share in cash and investments, including ones categorized as long term (it has no debt), and the valuation has dropped to less that 14.5x the 2013 consensus EPS estimate of $5.39.

There could be a near-term slowdown and the F5 could certainly disappoint when it reports earnings next week, but this is a high-quality tech name on sale, and it's one we're happy to dip a toe into and then buy more if it experiences any post-earnings weakness. As such, we're going to add F5 to the Recommended List with a "Buy" rating and a $120 target.

Learn more about this financial newsletter at Geoffrey Seiler's BullMarket.com.

Related articles:


Advertisement
Banner
News Flash

US Natural Gas ETF: On a roll
by Doug Fabian, editor Successful Investing

One area I think is ready for a new buy is natural gas. After experiencing a sharp decline from November through early January, natural gas prices have been on a roll.


Read more...

 

Split buys? HOMB and Noble Energy
by Neil Macneale, editor 2-for-1 Stock Split Newsletter

Each month, we add one stock to our model portfolio based upon those companies that have announced 2-for-1 stock splits; after a meager number of splits over the past year, we have a nice collection of six splits elect from this month.


Read more...


   

WisdomTree targets global bonds
by Mark Salzinger, editor The Investor's ETF Report

While most investors diversify the equity portions of their portfolio with allocations to foreign stocks, few diversify their bond holdings internationally. WisdomTree recently introduced the first ETF to invest in a truly global portfolio of corporate bonds.


Read more...

 

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...

 

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary